Cancer Risk clinical trials at UCSF

1 research study open to eligible people

Cancer risk is how likely a person is to develop cancer. UCSF is running studies that use supplemental MRI to find breast cancer earlier. UCSF is validating AI models that read scans to report detection rates.

Showing trials for

  • Mirai-MRI: Validation of AI Models for Breast Cancer Risk

    open to eligible females ages 40-89

    This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.

    San Francisco, California and other locations

Our lead scientists for Cancer Risk research studies include .

Last updated: